Jennifer Tousignant
Consigliere Generale presso VIRIDIAN THERAPEUTICS, INC.
Profilo
Jennifer Tousignant is currently the Chief Legal Officer at Viridian Therapeutics, Inc. She previously worked as the Senior Vice President-Legal at Sana Biotechnology, Inc. and as a Member-Global Launch Teams at Genzyme Corp.
In addition, she served as the Head-Legal at Xilio Therapeutics, Inc. in 2020 and as the Chief Intellectual Property Counsel at Tesaro, Inc. from 2016 to 2019.
Ms. Tousignant completed her undergraduate studies at the University of Virginia and obtained a graduate degree from Suffolk University Law School.
Posizioni attive di Jennifer Tousignant
| Società | Posizione | Inizio |
|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Consigliere Generale | 15/02/2024 |
Precedenti posizioni note di Jennifer Tousignant
| Società | Posizione | Fine |
|---|---|---|
| XILIO THERAPEUTICS, INC. | Consigliere Generale | 01/11/2020 |
| TESARO INC | Consigliere Generale | 01/10/2019 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
| SANA BIOTECHNOLOGY, INC. | Consigliere Generale | - |
Formazione di Jennifer Tousignant
| Suffolk University Law School | Graduate Degree |
| University of Virginia | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Health Technology |
| SANA BIOTECHNOLOGY, INC. | Health Technology |
| XILIO THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Jennifer Tousignant
